HEMATOLOGIC CANCER
Clinical trials for HEMATOLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC CANCER trials appear
Sign up with your email to follow new studies for HEMATOLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early study tests a new drug called ABBV-101 in people with several types of non-Hodgkin lymphoma that have come back or not responded to other treatments. The drug is a pill that targets a protein (BTK) involved in cancer growth. The main goals are to find a safe dose and s…
Matched conditions: HEMATOLOGIC CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Testosterone gel trial aims to beat cancer fatigue in older men
Symptom relief OngoingThis study is testing whether a daily testosterone gel can reduce fatigue and improve sexual function in men aged 55 and older who have cancer and low testosterone. The trial involves 230 participants who will apply either the gel or a placebo for six months. Researchers will mea…
Matched conditions: HEMATOLOGIC CANCER
Phase: PHASE2 • Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Spirituality may be key to coping with blood cancer from day one
Knowledge-focused TerminatedThis study looks at how spirituality — personal beliefs, values, and meaning — influences adults recently diagnosed with blood cancers like lymphoma or leukemia, as well as their loved ones. Participants fill out three questionnaires about spiritual well-being, quality of life, a…
Matched conditions: HEMATOLOGIC CANCER
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC